Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | GH | JAZZ | ||
| Company | Genmab A/S ADR | Guardant Health Inc | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.87 | 125.27 | 236.88 | ||
| High | 25.17 | 130.36 | 239.15 | ||
| Low | 24.70 | 122.76 | 228.52 | ||
| Latest | 25.10 | 130.12 | 229.19 | ||
| Change | +0.30 | +5.23 | -2.85 | ||
| % Change | +1.21% | +4.19% | -1.23% | ||
| Volume | 1,329,400 | 2,258,200 | 727,800 | ||
| 20-Day Average Volume | 2,044,325 | 2,529,175 | 927,235 | ||
| Previous Close | 24.80 | 124.89 | 232.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.01 | 117.40 | 234.08 | ||
| 20-Day Raw Stochastic | 39.52% | 90.04% | 27.43% | ||
| 20-Day Relative Strength | 43.28 | 66.38 | 55.52 | ||
| Weighted Alpha | -0.36 | +116.90 | +103.50 | ||
| Today's Opinion | 100% Sell | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | ||
| Last Month's Opinion | 64% Sell | 16% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.24% since 06/02/26 | -0.04% since 06/02/26 | +1.36% since 06/02/26 | ||
| Low | 23.62 on 06/03/26 | 122.76 on 06/09/26 | 224.99 on 06/03/26 | ||
| High | 25.29 on 06/05/26 | 134.28 on 06/04/26 | 241.99 on 06/05/26 | ||
| 1-Month | |||||
| %Chg | -5.03% since 05/08/26 | +35.97% since 05/08/26 | +1.51% since 05/08/26 | ||
| Low | 23.62 on 06/03/26 | 92.50 on 05/15/26 | 221.29 on 05/11/26 | ||
| High | 27.36 on 05/20/26 | 134.28 on 06/04/26 | 243.32 on 05/22/26 | ||
| 3-Month | |||||
| %Chg | -7.86% since 03/09/26 | +42.68% since 03/09/26 | +23.62% since 03/09/26 | ||
| Low | 23.62 on 06/03/26 | 74.55 on 04/10/26 | 177.58 on 03/13/26 | ||
| High | 29.43 on 04/14/26 | 134.28 on 06/04/26 | 243.32 on 05/22/26 | ||
| 6-Month | |||||
| %Chg | -18.85% since 12/09/25 | +26.07% since 12/09/25 | +41.25% since 12/09/25 | ||
| Low | 23.62 on 06/03/26 | 74.55 on 04/10/26 | 156.95 on 01/08/26 | ||
| High | 35.43 on 01/14/26 | 134.28 on 06/04/26 | 243.32 on 05/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,650,629 | 17,253,912 | 14,380,069 | ||
| Shares Outstanding, K | 623,531 | 132,600 | 62,743 | ||
| Annual Sales | 3,720,000,000 | 982,020,000 | 4,267,590,000 | ||
| Annual Net Income | 963,000,000 | -416,280,000 | -356,150,000 | ||
| Last Quarter Sales | 896,000,000 | 301,670,000 | 1,068,900,000 | ||
| Last Quarter Net Income | 53,000,000 | -112,080,000 | 293,100,000 | ||
| 60-Month Beta | 0.85 | 1.61 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/07/26 | -0.45 on 05/07/26 | 6.34 on 05/05/26 | ||
| Earnings Date | 08/06/26 | 07/29/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.84 | 0.00 | 25.39 | ||